Cat: IPD-X28533

Recombinant Human CNOT9 Protein,Strep & His

  • Price
  • Size
  • Number

    Order now. For delivery time, please consult customer service

  • Pre-sale guidance and worry-free after-sale service
  • Quality assurance for cold chain transportation

Analytical Data

  • Gene name

    CNOT9

  • Application

    SPRMSTBLIITCELISACELL ASSAYDRUG SCREENING

  • Alternative Names

    RCD1; RQCD1

  • Species

    Human

  • Source

    E. coli

  • Tag

    Strep;His

  • Purity

    Greater than 90% as determined by SDS-PAGE.

  • Uniprot

    Q92600-1

  • Expression Region

    M1-Q299

  • Protein Length

    Full Length of Isoform-1

  • Endotoxin

    < 1.0 EU per μg protein as determined by the LAL method.

  • Form

    Freeze-dried powder

  • Buffer formulation

    PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.

  • Reconstitution

    Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.

  • Customization

    Site-directed mutagenesis Custom tag design Custom buffer formulation Custom full-length protein production

  • Stability Test

    The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.

  • Storage & Shelf Life

    Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.

  • Shipping

    In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.

Quality inspection process

Related Products

Protein Description

CNOT9, a member of the CCR4-NOT complex, plays a crucial role in post-transcriptional regulation, including mRNA degradation and translation control. This protein has gained attention in recent years due to its implications in various biological processes and diseases, particularly in cancer and neurological disorders. Research has shown that CNOT9 is involved in the modulation of gene expression patterns, impacting cellular responses to stress and developmental cues. Additionally, its interactions with other proteins and RNA molecules highlight its importance in maintaining cellular homeostasis. Understanding the function and mechanism of CNOT9 can provide insights into novel therapeutic strategies for diseases where this protein is implicated. The recombinant expression of CNOT9 is essential for biochemical studies, allowing researchers to investigate its structure, function, and interactions in detail. By characterizing CNOT9, scientists aim to uncover potential roles in regulating gene expression networks and identify how perturbations in its function could lead to pathological conditions. This research is pivotal for advancing our knowledge of cellular mechanism and developing targeted interventions in CNOT9-related diseases.

E-mail

sales@ipodix.com

Sales

+1 2092920560


Contact us via WhatsApp

IPODIX Biotech Inc

2108 N ST, STE N
Sacramento, CA 95816, USA

For Product Information and Orders

sales@ipodix.com

For Business Collaboration

sales@ipodix.com

For CRO Services

sales@ipodix.com

For Technical Support

sales@ipodix.com
  • 50000+

    Recombinant Proteins

  • 100+

    Researchers

  • 100+

    Countries Served

  • ISO

    Certified Quality

Committed to Quality
Driven by Innovation

Learn More About US